Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of ...

Signal intensity depends on distance of target focus from receptor camera The use of imaging to evaluate peritoneal disease in ovarian cancer is essential for patient stratification to receive ...

National Cancer Institute, Singapore (NCIS), the Yong Loo Lin School of Medicine, National University of Singapore, Duke-NUS Medical School and National Cancer Centre Singapore (NCCS) unveil findings ...

In tandem with this breakthrough, a clinical trial has demonstrated the potential of an innovative treatment strategy ...

The clinical trial and a new study mark a significant leap in the fight against gastric cancer with peritoneal spread. Read ...

Sarcomatoid carcinomas of the stomach are rare and carry a poor prognosis. Surgical resection remains the primary treatment, though recurrence rates are high, and survival is limited. Further research ...

Pamiparib is under clinical development by BeiGene and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II drugs for Peritoneal Cancer have a 37% phase transition success ...

OSLO, Norway, August 28, 2024--(BUSINESS WIRE)--Oncoinvent ASA, a clinical stage radiopharmaceutical company advancing alpha emitter therapy across a variety of peritoneal metastases, today ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of ...

For gastric cancer, the peritoneum is, in fact, the most common site of metastasis, both before and after treatments. Patients with gastric cancer peritoneal metastases (GCPM) often face an ...